Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

Therapeutic Hypothermia After Cardiac Arrest

John McPherson

COVID-19 & ICU FAQ Answered: When Should We Intubate & How Do We Adj…

Hassan Bencheqroun MD FCCP

Sepsis Roundtable: Best Practices and Future Directions

PulmPEEPs

D. Furfaro, K. Montemayor, D. Angus, H. Prescott

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

PEEP Titration in ARDS Roundtable

PulmPEEPs

D. Furfaro, K. Montemayor, S. Sahetya, T. Rice, E. Baedorf-Kassis, R. Brower

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Evaluation of Patients With Undifferentiated Shock

PulmPEEPs

D. Furfaro, K. Montemayor, M. Hayes, N. Mark, M. Siuba

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

TCT 2024 Insights: Insights from the DanGer Shock and ECLS-Shock Tri…

TCT 2024 Insights

G. Tarantini

ECMO for Refractory Cardiac Arrest: Mobile MN Community Efforts and …

University of Minnesota

D. Yannopoulos

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Critical Care Literature Review

Medical College of Georgia - Augusta University

W. T Browne

State of Sepsis Care at Houston Methodist Hospital

Houston Methodist

F. Masud